The Milken Institute has ranked the University of Washington 7th in technology transfer, largely due to its success in licensing medical, biological, engineering, computing and other innovations
The UW received the highest score in licenses issued. It was the only institution to file more than 1,000 licenses between 2012-2015.
Its licensing income of $42.8 million in 2015 was another strength pushing up its placement in the rankings. It was ranked 24th in the nation in 2006.
The Milken Institute is a non-profit, non-partisan think tank seeking to foster global prosperity through solutions that widen access to capital, create jobs, promote industry expansion and improve health.
Its latest report, “Concept to Commercialization: The Best Universities for Technology Transfer” attributed the UW’s rise, in part, to the restructuring of CoMotion, a collaborative innovation hub that expands the economic and social impact of UW discoveries.
The report also highlights the success of the UW School of Medicine faculty in bringing in more than half of the $1 billion federal research grants awarded to the UW in 2016.
It also mentioned that 27 percent of the start-ups in the CoMotion labs were in the biotech and health-care fields.
While not listed specifically in the Milken report, a few examples of start up companies launched in 2015 from UW medical advances are:
Aoartic Corporation: This company is developing patient-specific treatments for abdominal aortic aneurysms precisely matched to their anatomy. It is based on advances by UW Medicine vascular and endovascular surgeons and their collaborators.
C-SATS: A performance management system, created by UW Medicine urologists, UW engineers and others, evaluates and helps improve technical skills in the health professions.
Cyrus Biotechnology: Easy-to-use software packages are produced by UW Medicine biochemists, UW computer scientists and others to engineer new drugs based on protein molecule design.
EpiThany is a clinical-stage biotech company working on therapeutic vaccines against solid tumors. It stems from findings by UW cancer researchers.
Novuson Surgical: This company is looking at the potential of ultrasound energy to control excessive bleeding from traumatic injuries and during clinical procedures. It is based bioengineering, physics and medical advances in applying high intensity focused ultrasound.